Protherics PLC Notification of Directors' Interests London, UK; Brentwood, TN, US; 12 June 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, today announces the award, on 11 June 2007, of a conditional right to receive 151,396 ordinary shares in Protherics ("Ordinary Shares") at a price of 2 pence each under the terms of the Protherics PLC 2005 Long Term Incentive Plan (the "LTIP"), to Saul Komisar, President of the Company's US operations. In addition to the above award, on 11 June 2007, Saul Komisar received a performance bonus in the form of a conditional right to acquire 50,177 Ordinary Shares at a price of 2 pence each under the terms of the Protherics PLC 2005 Deferred Bonus Plan. Following the above awards, Saul Komisar holds options and conditional awards over a total of 1,113,101 Ordinary Shares. Protherics PLC also announces the grant, on 11 June 2007, of the following options over Ordinary Shares in the Company under the terms of the LTIP at an exercise price of 2 pence per share: Name Position Number of Options Andrew Heath Chief Executive Officer 297,661 Barrington Riley Finance Director 161,702 James Christie Operations Director 161,702 Following the above grant of options, the above Directors hold options over the following number of Ordinary Shares: Andrew Heath 3,919,561 Barrington Riley 1,576,844 James Christie 1,388,010 | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange
Protherics PLC announces Director/PDMR Shareholding
| Source: Protherics PLC
Cheshire, UK--(Marketwire - June 12, 2007) -